{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:20:35Z","timestamp":1774610435058,"version":"3.50.1"},"publisher-location":"Totowa, NJ","reference-count":239,"publisher":"Humana Press","isbn-type":[{"value":"9781603273640","type":"print"},{"value":"9781603273657","type":"electronic"}],"license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1007\/978-1-60327-365-7_2","type":"book-chapter","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T10:55:38Z","timestamp":1270637738000},"page":"9-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clostridium difficile and the Disease It Causes"],"prefix":"10.1007","author":[{"given":"Torbj\u00f6rn","family":"Nor\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,8]]},"reference":[{"key":"2_CR1","first-page":"584","volume-title":"Gastroenterology","author":"A Novogrudsky","year":"2003","unstructured":"Novogrudsky A and Plaut AG. (2003) The bacterial flora of the healthy gastrointestinal tract: colonization of the human colon. In: Yamada T, ed., Gastroenterology, 4th ed., Lippincott Williams & Wilkins, Philadelphia, 584\u2013585.","edition":"4"},{"key":"2_CR2","first-page":"893","volume":"77","author":"DC Savage","year":"1981","unstructured":"Savage DC. (1981) The microbial flora in the gastrointestinal tract. Prog Clin Biol Res\n                           77, 893\u2013908.","journal-title":"Prog Clin Biol Res"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/jn\/134.2.459","volume":"134","author":"V Mai","year":"2004","unstructured":"Mai V and Morris JG, Jr. (2004) Colonic bacterial flora: changing understandings in the molecular age. J Nutr\n                           134, 459\u2013464.","journal-title":"J Nutr"},{"key":"2_CR4","first-page":"9","volume":"35","author":"G Evaldson","year":"1982","unstructured":"Evaldson G, Heimdahl A, Kager L and Nord CE. (1982) The normal human anaerobic microflora. Scand J Infect Dis Suppl\n                           35, 9\u201315.","journal-title":"Scand J Infect Dis Suppl"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1128\/AAC.38.3.409","volume":"38","author":"EJ Vollaard","year":"1994","unstructured":"Vollaard EJ and Clasener HA. (1994) Colonization resistance. Antimicrob Agents Chemother\n                           38, 409\u2013414.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1099\/00222615-45-2-133","volume":"45","author":"N Al Saif","year":"1996","unstructured":"Al Saif N and Brazier JS. (1996) The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol\n                           45, 133\u2013137.","journal-title":"J Med Microbiol"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CMR.3.1.66","volume":"3","author":"CL Hatheway","year":"1990","unstructured":"Hatheway CL. (1990) Toxigenic clostridia. Clin Microbiol Rev\n                           3, 66\u201398.","journal-title":"Clin Microbiol Rev"},{"key":"2_CR8","volume-title":"Medical Microbiology","author":"PR Murray","year":"2005","unstructured":"Murray PR. (2005) Clostridium. In: Murray PR, Rosenthal KS and Pfaller MA, eds., Medical Microbiology, 5th ed., Mosby, St. Louis.","edition":"5"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/smim.1999.0174","volume":"11","author":"N Debard","year":"1999","unstructured":"Debard N, Sierro F and Kraehenbuhl JP. (1999) Development of Peyer\u2019s patches, follicle-associated epithelium and M cell: lessons from immunodeficient and knockout mice. Semin Immunol\n                           11, 183\u2013191.","journal-title":"Semin Immunol"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM199401273300406","volume":"330","author":"CP Kelly","year":"1994","unstructured":"Kelly CP, Pothoulakis C and LaMont JT. (1994) Clostridium difficile colitis. N Engl J Med\n                           330, 257\u2013262.","journal-title":"N Engl J Med"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1172\/JCI115957","volume":"90","author":"R Eglow","year":"1992","unstructured":"Eglow R, Pothoulakis C, Itzkowitz S, et al. (1992) Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest\n                           90, 822\u2013829.","journal-title":"J Clin Invest"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/BF01964052","volume":"8","author":"K Tullus","year":"1989","unstructured":"Tullus K, Aronsson B, Marcus S and Mollby R. (1989) Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur J Clin Microbiol Infect Dis\n                           8, 390\u2013393.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1086\/501990","volume":"23","author":"JM Langley","year":"2002","unstructured":"Langley JM, LeBlanc JC, Hanakowski M and Goloubeva O. (2002) The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Infect Control Hosp Epidemiol\n                           23, 660\u2013664.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/infdis\/148.1.93","volume":"148","author":"R Viscidi","year":"1983","unstructured":"Viscidi R, Laughon BE, Yolken R, et al. (1983) Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis\n                           148, 93\u2013100.","journal-title":"J Infect Dis"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.med.49.1.375","volume":"49","author":"CP Kelly","year":"1998","unstructured":"Kelly CP and LaMont JT. (1998) Clostridium difficile infection. Annu Rev Med\n                           49, 375\u2013390.","journal-title":"Annu Rev Med"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0140-6736(00)03582-0","volume":"357","author":"M Wilcox","year":"2001","unstructured":"Wilcox M and Minton J. (2001) Role of antibody response in outcome of antibiotic-associated diarrhoea. Lancet\n                           357, 158\u2013159.","journal-title":"Lancet"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(97)08062-8","volume":"351","author":"JK Shim","year":"1998","unstructured":"Shim JK, Johnson S, Samore MH, Bliss DZ and Gerding DN. (1998) Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet\n                           351, 633\u2013636.","journal-title":"Lancet"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0022-3476(05)83393-1","volume":"118","author":"DY Leung","year":"1991","unstructured":"Leung DY, Kelly CP, Boguniewicz M, Pothoulakis C, LaMont JT and Flores A. (1991) Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr\n                           118, 633\u2013637.","journal-title":"J Pediatr"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1128\/iai.63.8.3166-3173.1995","volume":"63","author":"S Johnson","year":"1995","unstructured":"Johnson S, Sypura WD, Gerding DN, Ewing SL and Janoff EN. (1995) Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect Immun\n                           63, 3166\u20133173.","journal-title":"Infect Immun"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1056\/NEJM200002103420604","volume":"342","author":"L Kyne","year":"2000","unstructured":"Kyne L, Warny M, Qamar A and Kelly CP. (2000) Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med\n                           342, 390\u2013397.","journal-title":"N Engl J Med"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/iai.59.3.1192-1195.1991","volume":"59","author":"G Corthier","year":"1991","unstructured":"Corthier G, Muller MC, Wilkins TD, Lyerly D and L\u2019Haridon R. (1991) Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. Infect Immun\n                           59, 1192\u20131195.","journal-title":"Infect Immun"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/iai.62.2.384-389.1994","volume":"62","author":"M Warny","year":"1994","unstructured":"Warny M, Vaerman JP, Avesani V and Delmee M. (1994) Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun\n                           62, 384\u2013389.","journal-title":"Infect Immun"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-65-1-1","volume":"65","author":"MY Khan","year":"1966","unstructured":"Khan MY and Hall WH. (1966) Staphylococcal enterocolitis \u2013 treatment with oral vancomycin. Ann Intern Med\n                           65, 1\u20138.","journal-title":"Ann Intern Med"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-81-4-429","volume":"81","author":"FJ Tedesco","year":"1974","unstructured":"Tedesco FJ, Barton RW and Alpers DH. (1974) Clindamycin-associated colitis. A prospective study. Ann Intern Med\n                           81, 429\u2013433.","journal-title":"Ann Intern Med"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1136\/bmj.1.6071.1246","volume":"1","author":"HE Larson","year":"1977","unstructured":"Larson HE, Parry JV, Price AB, Davies DR, Dolby J and Tyrrell DA. (1977) Undescribed toxin in pseudomembranous colitis. Br Med J\n                           1, 1246\u20131248.","journal-title":"Br Med J"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0016-5085(78)90844-2","volume":"75","author":"GD Rifkin","year":"1978","unstructured":"Rifkin GD, Fekety R and Silva J. (1978) Neutralization by Clostridium sordellii antitoxin of toxins implicated in clindamycin-induced cecitis in the hamster. Gastroenterology\n                           75, 422\u2013424.","journal-title":"Gastroenterology"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJM197803092981003","volume":"298","author":"JG Bartlett","year":"1978","unstructured":"Bartlett JG, Chang TW, Gurwith M, Gorbach SL and Onderdonk AB. (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med\n                           298, 531\u2013534.","journal-title":"N Engl J Med"},{"key":"2_CR28","first-page":"439","volume":"90","author":"LV McFarland","year":"1995","unstructured":"McFarland LV, Surawicz CM, Greenberg RN, et al. (1995) Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol\n                           90, 439\u2013448.","journal-title":"Am J Gastroenterol"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-110-4-255","volume":"110","author":"DN Gerding","year":"1989","unstructured":"Gerding DN. (1989) Disease associated with Clostridium difficile infection. Ann Intern Med\n                           110, 255\u2013257.","journal-title":"Ann Intern Med"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1128\/JCM.42.8.3635-3643.2004","volume":"42","author":"T Nor\u00e9n","year":"2004","unstructured":"Nor\u00e9n T, \u00c5kerlund T, B\u00e4ck E, et al. (2004) Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol\n                           42, 3635\u20133643.","journal-title":"J Clin Microbiol"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/clind\/15.4.573","volume":"15","author":"JG Bartlett","year":"1992","unstructured":"Bartlett JG. (1992) Antibiotic-associated diarrhea. Clin Infect Dis\n                           15, 573\u2013581.","journal-title":"Clin Infect Dis"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/j.1572-0241.2005.41510.x","volume":"100","author":"JM Boyce","year":"2005","unstructured":"Boyce JM and Havill NL. (2005) Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol\n                           100, 1828\u20131834.","journal-title":"Am J Gastroenterol"},{"key":"2_CR33","first-page":"BR85","volume":"8","author":"H Pituch","year":"2002","unstructured":"Pituch H, van den Braak N, van Belkum A, et al. (2002) Characterization of Clostridium perfringens strains isolated from Polish patients with suspected antibiotic-associated diarrhea. Med Sci Monit\n                           8, BR85\u2013BR88.","journal-title":"Med Sci Monit"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.diagmicrobio.2006.01.026","volume":"55","author":"SH Cohen","year":"2006","unstructured":"Cohen SH, Shetab R, Tang-Feldman YJ, Sarma P, Silva J, Jr. and Prindiville TP. (2006) Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired diarrhea. Diagn Microbiol Infect Dis\n                           55, 251\u2013254.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0140-6736(91)91296-7","volume":"337","author":"PL Danna","year":"1991","unstructured":"Danna PL, Urban C, Bellin E and Rahal JJ. (1991) Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. Lancet\n                           337, 511\u2013514.","journal-title":"Lancet"},{"key":"2_CR36","first-page":"81","volume":"34","author":"SE Hovius","year":"1982","unstructured":"Hovius SE and Rietra PJ. (1982) Salmonella colitis clinically presenting as a pseudomembranous colitis. Neth J Surg\n                           34, 81\u201382.","journal-title":"Neth J Surg"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/iai.35.3.1032-1040.1982","volume":"35","author":"NM Sullivan","year":"1982","unstructured":"Sullivan NM, Pellett S and Wilkins TD. (1982) Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun\n                           35, 1032\u20131040.","journal-title":"Infect Immun"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1016\/S0021-9258(17)34116-9","volume":"269","author":"I Just","year":"1994","unstructured":"Just I, Fritz G, Aktories K, et al. (1994) Clostridium difficile toxin B acts on the GTP-binding protein Rho. J Biol Chem\n                           269, 10706\u201310712.","journal-title":"J Biol Chem"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/375500a0","volume":"375","author":"I Just","year":"1995","unstructured":"Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M and Aktories K. (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature\n                           375, 500\u2013503.","journal-title":"Nature"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"13932","DOI":"10.1074\/jbc.270.23.13932","volume":"270","author":"I Just","year":"1995","unstructured":"Just I, Wilm M, Selzer J, et al. (1995) The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem\n                           270, 13932\u201313936.","journal-title":"J Biol Chem"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1016\/j.vaccine.2007.02.055","volume":"25","author":"S Pechine","year":"2007","unstructured":"Pechine S, Janoir C, Boureau H, et al. (2007) Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile. Vaccine\n                           25, 3946\u20133954.","journal-title":"Vaccine"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0966-842X(96)10061-5","volume":"4","author":"C von Eichel-Streiber","year":"1996","unstructured":"von Eichel-Streiber C, Boquet P, Sauerborn M and Thelestam M. (1996) Large clostridial cytotoxins \u2013 a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol\n                           4, 375\u2013382.","journal-title":"Trends Microbiol"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0016-5085(87)91014-6","volume":"93","author":"G Triadafilopoulos","year":"1987","unstructured":"Triadafilopoulos G, Pothoulakis C, O\u2019Brien MJ and LaMont JT. (1987) Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology\n                           93, 273\u2013279.","journal-title":"Gastroenterology"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.30.1.1","volume":"30","author":"AB Price","year":"1977","unstructured":"Price AB and Davies DR. (1977) Pseudomembranous colitis. J Clin Pathol\n                           30, 1\u201312.","journal-title":"J Clin Pathol"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/iai.60.11.4633-4639.1992","volume":"60","author":"DM Lyerly","year":"1992","unstructured":"Lyerly DM, Barroso LA, Wilkins TD, Depitre C and Corthier G. (1992) Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun\n                           60, 4633\u20134639.","journal-title":"Infect Immun"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/iai.36.2.822-829.1982","volume":"36","author":"JM Libby","year":"1982","unstructured":"Libby JM, Jortner BS and Wilkins TD. (1982) Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun\n                           36, 822\u2013829.","journal-title":"Infect Immun"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1128\/iai.56.9.2299-2306.1988","volume":"56","author":"MR Popoff","year":"1988","unstructured":"Popoff MR, Rubin EJ, Gill DM and Boquet P. (1988) Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun\n                           56, 2299\u20132306.","journal-title":"Infect Immun"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1128\/JCM.42.5.1933-1939.2004","volume":"42","author":"C Goncalves","year":"2004","unstructured":"Goncalves C, Decre D, Barbut F, Burghoffer B and Petit JC. (2004) Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol\n                           42, 1933\u20131939.","journal-title":"J Clin Microbiol"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000016879","volume":"16","author":"LV McFarland","year":"1998","unstructured":"McFarland LV. (1998) Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis\n                           16, 292\u2013307.","journal-title":"Dig Dis"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/iai.34.2.626-628.1981","volume":"34","author":"KH Wilson","year":"1981","unstructured":"Wilson KH, Silva J and Fekety FR. (1981) Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect Immun\n                           34, 626\u2013628.","journal-title":"Infect Immun"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/iai.28.1.277-282.1980","volume":"28","author":"AB Onderdonk","year":"1980","unstructured":"Onderdonk AB, Cisneros RL and Bartlett JG. (1980) Clostridium difficile in gnotobiotic mice. Infect Immun\n                           28, 277\u2013282.","journal-title":"Infect Immun"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1099\/00222615-21-4-299","volume":"21","author":"SP Borriello","year":"1986","unstructured":"Borriello SP and Barclay FE. (1986) An in-vitro model of colonisation resistance to Clostridium difficile infection. J Med Microbiol\n                           21, 299\u2013309.","journal-title":"J Med Microbiol"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/367657","volume":"36","author":"J Aas","year":"2003","unstructured":"Aas J, Gessert CE and Bakken JS. (2003) Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis\n                           36, 580\u2013585.","journal-title":"Clin Infect Dis"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S0140-6736(89)92749-9","volume":"1","author":"M Tvede","year":"1989","unstructured":"Tvede M and Rask-Madsen J. (1989) Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet\n                           1, 1156\u20131160.","journal-title":"Lancet"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/infdis\/151.3.476","volume":"151","author":"B Aronsson","year":"1985","unstructured":"Aronsson B, Mollby R and Nord CE. (1985) Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980\u20131982. J Infect Dis\n                           151, 476\u2013481.","journal-title":"J Infect Dis"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0140-6736(78)90912-1","volume":"1","author":"HE Larson","year":"1978","unstructured":"Larson HE, Price AB, Honour P and Borriello SP. (1978) Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet\n                           1, 1063\u20131066.","journal-title":"Lancet"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1348-0421.1981.tb00036.x","volume":"25","author":"S Nakamura","year":"1981","unstructured":"Nakamura S, Mikawa M, Nakashio S, et al. (1981) Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol\n                           25, 345\u2013351.","journal-title":"Microbiol Immunol"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0016-5085(81)90644-2","volume":"81","author":"R Viscidi","year":"1981","unstructured":"Viscidi R, Willey S and Bartlett JG. (1981) Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology\n                           81, 5\u20139.","journal-title":"Gastroenterology"},{"issue":"1","key":"2_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1365-2036.2004.01969.x","volume":"20","author":"M Iizuka","year":"2004","unstructured":"Iizuka M, Itou H, Konno S, et al. (2004) Elemental diet modulates the growth of Clostridium difficile in the gut flora. Aliment Pharmacol Ther\n                           20(Suppl 1), 151\u2013157.","journal-title":"Aliment Pharmacol Ther"},{"issue":"C","key":"2_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/jac\/41.suppl_3.47","volume":"41","author":"JS Brazier","year":"1998","unstructured":"Brazier JS. (1998) The epidemiology and typing of Clostridium difficile. J Antimicrob Chemother\n                           41(Suppl C), 47\u201357.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1056\/NEJM198901263200402","volume":"320","author":"LV McFarland","year":"1989","unstructured":"McFarland LV, Mulligan ME, Kwok RY and Stamm WE. (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med\n                           320, 204\u2013210.","journal-title":"N Engl J Med"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1086\/525267","volume":"46","author":"GS Bobulsky","year":"2008","unstructured":"Bobulsky GS, Al-Nassir WN, Riggs MM, Sethi AK and Donskey CJ. (2008) Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis\n                           46, 447\u2013450.","journal-title":"Clin Infect Dis"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1086\/521854","volume":"45","author":"MM Riggs","year":"2007","unstructured":"Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL and Donskey CJ. (2007) Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis\n                           45, 992\u2013998.","journal-title":"Clin Infect Dis"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/jac\/23.4.623","volume":"23","author":"F de Lalla","year":"1989","unstructured":"de Lalla F, Privitera G, Ortisi G, et al. (1989) Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital. J Antimicrob Chemother\n                           23, 623\u2013631.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00019053-199610010-00001","volume":"10","author":"TV Riley","year":"1996","unstructured":"Riley TV. (1996) Antibiotic-associated diarrhoea. A costly problem. PharmacoEconomics\n                           10, 1\u20133.","journal-title":"PharmacoEconomics"},{"issue":"C","key":"2_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jac\/41.suppl_3.21","volume":"41","author":"RC Spencer","year":"1998","unstructured":"Spencer RC. (1998) The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother\n                           41(Suppl C), 21\u201327.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1001\/archinte.1986.00360130117016","volume":"146","author":"DN Gerding","year":"1986","unstructured":"Gerding DN, Olson MM, Peterson LR, et al. (1986) Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med\n                           146, 95\u2013100.","journal-title":"Arch Intern Med"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/jac\/30.2.141","volume":"30","author":"CL Golledge","year":"1992","unstructured":"Golledge CL, Carson CF, O\u2019Neill GL, Bowman RA and Riley TV. (1992) Ciprofloxacin and Clostridium difficile-associated diarrhoea. J Antimicrob Chemother\n                           30, 141\u2013147.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1086\/381551","volume":"38","author":"R Gaynes","year":"2004","unstructured":"Gaynes R, Rimland D, Killum E, et al. (2004) Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis\n                           38, 640\u2013645.","journal-title":"Clin Infect Dis"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1086\/422525","volume":"39","author":"A Khurana","year":"2004","unstructured":"Khurana A, Vinayek N, Recco RA, Go ES and Zaman MM. (2004) The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility. Clin Infect Dis\n                           39, 602\u2013603.","journal-title":"Clin Infect Dis"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J Pepin","year":"2005","unstructured":"Pepin J, Saheb N, Coulombe MA, et al. (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis\n                           41, 1254\u20131260.","journal-title":"Clin Infect Dis"},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1056\/NEJMoa051639","volume":"353","author":"VG Loo","year":"2005","unstructured":"Loo VG, Poirier L, Miller MA, et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med\n                           353, 2442\u20132449.","journal-title":"N Engl J Med"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"LC McDonald","year":"2005","unstructured":"McDonald LC, Killgore GE, Thompson A, et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med\n                           353, 2433\u20132441.","journal-title":"N Engl J Med"},{"key":"2_CR74","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1086\/342691","volume":"35","author":"C Thomas","year":"2002","unstructured":"Thomas C, Stevenson M, Williamson DJ and Riley TV. (2002) Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy. Clin Infect Dis\n                           35, 1457\u20131462.","journal-title":"Clin Infect Dis"},{"key":"2_CR75","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1086\/516277","volume":"26","author":"O Karlstrom","year":"1998","unstructured":"Karlstrom O, Fryklund B, Tullus K and Burman LG. (1998) A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish Clostridium difficile Study Group. Clin Infect Dis\n                           26, 141\u2013145.","journal-title":"Clin Infect Dis"},{"key":"2_CR76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/clinids\/17.1.109","volume":"17","author":"A Anand","year":"1993","unstructured":"Anand A and Glatt AE. (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis\n                           17, 109\u2013113.","journal-title":"Clin Infect Dis"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.7326\/0003-4819-129-12-199812150-00004","volume":"129","author":"DZ Bliss","year":"1998","unstructured":"Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K and Gerding DN. (1998) Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med\n                           129, 1012\u20131019.","journal-title":"Ann Intern Med"},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1503\/cmaj.1040876","volume":"171","author":"S Dial","year":"2004","unstructured":"Dial S, Alrasadi K, Manoukian C, Huang A and Menzies D. (2004) Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ\n                           171, 33\u201338.","journal-title":"CMAJ"},{"key":"2_CR79","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/infdis\/162.3.678","volume":"162","author":"LV McFarland","year":"1990","unstructured":"McFarland LV, Surawicz CM and Stamm WE. (1990) Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis\n                           162, 678\u2013684.","journal-title":"J Infect Dis"},{"key":"2_CR80","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1128\/IAI.68.10.5881-5888.2000","volume":"68","author":"S Karlsson","year":"2000","unstructured":"Karlsson S, Lindberg A, Norin E, Burman LG and \u00c5kerlund T. (2000) Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun\n                           68, 5881\u20135888.","journal-title":"Infect Immun"},{"issue":"4","key":"2_CR81","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1093\/clinids\/16.Supplement_4.S214","volume":"16","author":"KH Wilson","year":"1993","unstructured":"Wilson KH. (1993) The microecology of Clostridium difficile. Clin Infect Dis\n                           16(Suppl 4), S214\u2013S218.","journal-title":"Clin Infect Dis"},{"key":"2_CR82","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00000658-200203000-00008","volume":"235","author":"RM Dallal","year":"2002","unstructured":"Dallal RM, Harbrecht BG, Boujoukas AJ, et al. (2002) Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg\n                           235, 363\u2013372.","journal-title":"Ann Surg"},{"key":"2_CR83","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/QCO.0b013e32818be71d","volume":"20","author":"EJ Kuijper","year":"2007","unstructured":"Kuijper EJ, van Dissel JT and Wilcox MH. (2007) Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis\n                           20, 376\u2013383.","journal-title":"Curr Opin Infect Dis"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1503\/cmaj.1041104","volume":"171","author":"J Pepin","year":"2004","unstructured":"Pepin J, Valiquette L, Alary ME, et al. (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ\n                           171, 466\u2013472.","journal-title":"CMAJ"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1046\/j.1198-743x.2001.00294.x","volume":"7","author":"M Delmee","year":"2001","unstructured":"Delmee M. (2001) Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect\n                           7, 411\u2013416.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-117-4-297","volume":"117","author":"S Johnson","year":"1992","unstructured":"Johnson S, Homann SR, Bettin KM, et al. (1992) Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial. Ann Intern Med\n                           117, 297\u2013302.","journal-title":"Ann Intern Med"},{"key":"2_CR87","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0195-6701(99)90018-X","volume":"41","author":"T Djuretic","year":"1999","unstructured":"Djuretic T, Wall PG and Brazier JS. (1999) Clostridium difficile: an update on its epidemiology and role in hospital outbreaks in England and Wales. J Hosp Infect\n                           41, 213\u2013218.","journal-title":"J Hosp Infect"},{"key":"2_CR88","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/archinte.161.4.525","volume":"161","author":"E Mylonakis","year":"2001","unstructured":"Mylonakis E, Ryan ET and Calderwood SB. (2001) Clostridium difficile \u2013 associated diarrhea: a review. Arch Intern Med\n                           161, 525\u2013533.","journal-title":"Arch Intern Med"},{"key":"2_CR89","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/jcm.31.4.963-967.1993","volume":"31","author":"F Barbut","year":"1993","unstructured":"Barbut F, Kajzer C, Planas N and Petit JC. (1993) Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol\n                           31, 963\u2013967.","journal-title":"J Clin Microbiol"},{"key":"2_CR90","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.1993.03500010081036","volume":"269","author":"R Fekety","year":"1993","unstructured":"Fekety R and Shah AB. (1993) Diagnosis and treatment of Clostridium difficile colitis. J Am Med Assoc\n                           269, 71\u201375.","journal-title":"J Am Med Assoc"},{"issue":"4","key":"2_CR91","doi-asserted-by":"publisher","first-page":"S439","DOI":"10.1093\/clinids\/16.Supplement_4.S439","volume":"16","author":"DN Gerding","year":"1993","unstructured":"Gerding DN and Brazier JS. (1993) Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis\n                           16(Suppl 4), S439\u2013S442.","journal-title":"Clin Infect Dis"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/BF01695667","volume":"15","author":"LR Peterson","year":"1996","unstructured":"Peterson LR, Kelly PJ and Nordbrock HA. (1996) Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis\n                           15, 330\u2013336.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2_CR93","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMcp011603","volume":"346","author":"JG Bartlett","year":"2002","unstructured":"Bartlett JG. (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med\n                           346, 334\u2013339.","journal-title":"N Engl J Med"},{"key":"2_CR94","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-135-6-200109180-00012","volume":"135","author":"S Johnson","year":"2001","unstructured":"Johnson S, Kent SA, O\u2019Leary KJ, et al. (2001) Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay. Ann Intern Med\n                           135, 434\u2013438.","journal-title":"Ann Intern Med"},{"key":"2_CR95","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1128\/JCM.02563-05","volume":"44","author":"DR MacCannell","year":"2006","unstructured":"MacCannell DR, Louie TJ, Gregson DB, et al. (2006) Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada. J Clin Microbiol\n                           44, 2147\u20132152.","journal-title":"J Clin Microbiol"},{"key":"2_CR96","first-page":"49","volume":"120","author":"AA Renshaw","year":"1996","unstructured":"Renshaw AA, Stelling JM and Doolittle MH. (1996) The lack of value of repeated Clostridium difficile cytotoxicity assays. Arch Pathol Lab Med\n                           120, 49\u201352.","journal-title":"Arch Pathol Lab Med"},{"key":"2_CR97","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/jcm.31.3.507-511.1993","volume":"31","author":"PH Gumerlock","year":"1993","unstructured":"Gumerlock PH, Tang YJ, Weiss JB and Silva J, Jr. (1993) Specific detection of toxigenic strains of Clostridium difficile in stool specimens. J Clin Microbiol\n                           31, 507\u2013511.","journal-title":"J Clin Microbiol"},{"key":"2_CR98","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/jcm.32.7.1629-1633.1994","volume":"32","author":"MJ Wolfhagen","year":"1994","unstructured":"Wolfhagen MJ, Fluit AC, Torensma R, Poppelier MJ and Verhoef J. (1994) Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay. J Clin Microbiol\n                           32, 1629\u20131633.","journal-title":"J Clin Microbiol"},{"key":"2_CR99","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1086\/646934","volume":"15","author":"MM Olson","year":"1994","unstructured":"Olson MM, Shanholtzer CJ, Lee JT, Jr. and Gerding DN. (1994) Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982\u20131991. Infect Control Hosp Epidemiol\n                           15, 371\u2013381.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2_CR100","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0016-5085(82)80136-4","volume":"83","author":"FJ Tedesco","year":"1982","unstructured":"Tedesco FJ, Corless JK and Brownstein RE. (1982) Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology\n                           83, 1259\u20131260.","journal-title":"Gastroenterology"},{"key":"2_CR101","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1111\/j.1572-0241.2000.03284.x","volume":"95","author":"M Bulusu","year":"2000","unstructured":"Bulusu M, Narayan S, Shetler K and Triadafilopoulos G. (2000) Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol\n                           95, 3137\u20133141.","journal-title":"Am J Gastroenterol"},{"key":"2_CR102","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1086\/511792","volume":"28","author":"ER Dubberke","year":"2007","unstructured":"Dubberke ER, Sadhu J, Gatti R, et al. (2007) Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system. Infect Control Hosp Epidemiol\n                           28, 208\u2013211.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2_CR103","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jinf.2007.09.015","volume":"55","author":"J Belmares","year":"2007","unstructured":"Belmares J, Gerding DN, Parada JP, Miskevics S, Weaver F and Johnson S. (2007) Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect\n                           55, 495\u2013501.","journal-title":"J Infect"},{"key":"2_CR104","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/BF02054220","volume":"38","author":"MS Rubin","year":"1995","unstructured":"Rubin MS, Bodenstein LE and Kent KC. (1995) Severe Clostridium difficile colitis. Dis Colon Rectum\n                           38, 350\u2013354.","journal-title":"Dis Colon Rectum"},{"key":"2_CR105","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"FA Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM and Davis MB. (2007) A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis\n                           45, 302\u2013307.","journal-title":"Clin Infect Dis"},{"key":"2_CR106","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/01.SMJ.0000054537.20978.D4","volume":"97","author":"MA Marinella","year":"2004","unstructured":"Marinella MA, Burdette SD, Bedimo R and Markert RJ. (2004) Leukemoid reactions complicating colitis due to Clostridium difficile. South Med J\n                           97, 959\u2013963.","journal-title":"South Med J"},{"key":"2_CR107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/archsurg.2007.46","volume":"143","author":"JC Byrn","year":"2008","unstructured":"Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ and Divino CM. (2008) Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg\n                           143, 150\u2013154, discussion 5.","journal-title":"Arch Surg"},{"key":"2_CR108","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.sla.0000236628.79550.e5","volume":"245","author":"F Lamontagne","year":"2007","unstructured":"Lamontagne F, Labbe AC, Haeck O, et al. (2007) Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg\n                           245, 267\u2013272.","journal-title":"Ann Surg"},{"key":"2_CR109","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/502539","volume":"26","author":"CA Muto","year":"2005","unstructured":"Muto CA, Pokrywka M, Shutt K, et al. (2005) A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol\n                           26, 273\u2013280.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2_CR110","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1503\/cmaj.050978","volume":"173","author":"J Pepin","year":"2005","unstructured":"Pepin J, Valiquette L and Cossette B. (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ\n                           173, 1037\u20131042.","journal-title":"CMAJ"},{"key":"2_CR111","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1086\/430311","volume":"40","author":"DM Musher","year":"2005","unstructured":"Musher DM, Aslam S, Logan N, et al. (2005) Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis\n                           40, 1586\u20131590.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2_CR112","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1469-0691.2006.01580.x","volume":"12","author":"EJ Kuijper","year":"2006","unstructured":"Kuijper EJ, Coignard B and Tull P. (2006) Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect\n                           12(Suppl 6), 2\u201318.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR113","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3201\/eid1205.051350","volume":"12","author":"EJ Kuijper","year":"2006","unstructured":"Kuijper EJ, van den Berg RJ, Debast S, et al. (2006) Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis\n                           12, 827\u2013830.","journal-title":"Emerg Infect Dis"},{"key":"2_CR114","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","volume":"366","author":"M Warny","year":"2005","unstructured":"Warny M, Pepin J, Fang A, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet\n                           366, 1079\u20131084.","journal-title":"Lancet"},{"key":"2_CR115","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1128\/JCM.01964-07","volume":"46","author":"T \u00c5kerlund","year":"2008","unstructured":"\u00c5kerlund T, Persson I, Unemo M, et al. (2008) Increased sporulation rate of epidemic Clostridium difficile Type 027\/NAP1. J Clin Microbiol\n                           46, 1530\u20131533.","journal-title":"J Clin Microbiol"},{"key":"2_CR116","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/511789","volume":"28","author":"P Biller","year":"2007","unstructured":"Biller P, Shank B, Lind L, et al. (2007) Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infect Control Hosp Epidemiol\n                           28, 198\u2013201.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"2_CR117","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1086\/519258","volume":"45","author":"L Valiquette","year":"2007","unstructured":"Valiquette L, Cossette B, Garant MP, Diab H and Pepin J. (2007) Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1\/027 strain. Clin Infect Dis\n                           45(Suppl 2), S112\u2013S121.","journal-title":"Clin Infect Dis"},{"key":"2_CR118","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/jac\/dkm014","volume":"59","author":"S Fowler","year":"2007","unstructured":"Fowler S, Webber A, Cooper BS, et al. (2007) Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother\n                           59, 990\u2013995.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2_CR119","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.1093\/clinids\/6.Supplement_1.S235","volume":"6","author":"JG Bartlett","year":"1984","unstructured":"Bartlett JG. (1984) Treatment of antibiotic-associated pseudomembranous colitis. Rev Infect Dis\n                           6(Suppl 1), S235\u2013S241.","journal-title":"Rev Infect Dis"},{"key":"2_CR120","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","volume":"2","author":"DG Teasley","year":"1983","unstructured":"Teasley DG, Gerding DN, Olson MM, et al. (1983) Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet\n                           2, 1043\u20131046.","journal-title":"Lancet"},{"key":"2_CR121","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","volume":"22","author":"C Wenisch","year":"1996","unstructured":"Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM and Graninger W. (1996) Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis\n                           22, 813\u2013818.","journal-title":"Clin Infect Dis"},{"key":"2_CR122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0195-6701(92)90092-Z","volume":"22","author":"MH Wilcox","year":"1992","unstructured":"Wilcox MH and Spencer RC. (1992) Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect\n                           22, 85\u201392.","journal-title":"J Hosp Infect"},{"key":"2_CR123","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0140-6736(78)91741-5","volume":"2","author":"F Tedesco","year":"1978","unstructured":"Tedesco F, Markham R, Gurwith M, Christie D and Bartlett JG. (1978) Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet\n                           2, 226\u2013228.","journal-title":"Lancet"},{"key":"2_CR124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0002-9343(89)90223-4","volume":"86","author":"R Fekety","year":"1989","unstructured":"Fekety R, Silva J, Kauffman C, Buggy B and Deery HG. (1989) Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med\n                           86, 15\u201319.","journal-title":"Am J Med"},{"key":"2_CR125","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/jcm.33.10.2770-2773.1995","volume":"33","author":"LL Dever","year":"1995","unstructured":"Dever LL, Smith SM, Handwerger S and Eng RH. (1995) Vancomycin-dependent Enterococcus faecium isolated from stool following oral vancomycin therapy. J Clin Microbiol\n                           33, 2770\u20132773.","journal-title":"J Clin Microbiol"},{"key":"2_CR126","first-page":"127","volume":"250","author":"DN Gerding","year":"2000","unstructured":"Gerding DN. (2000) Treatment of Clostridium difficile-associated diarrhea and colitis. Curr Top Microbiol Immunol\n                           250, 127\u2013139.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2_CR127","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/gut.27.10.1169","volume":"27","author":"RP Bolton","year":"1986","unstructured":"Bolton RP and Culshaw MA. (1986) Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut\n                           27, 1169\u20131172.","journal-title":"Gut"},{"key":"2_CR128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0025-7125(16)31446-8","volume":"66","author":"A Molavi","year":"1982","unstructured":"Molavi A, LeFrock JL and Prince RA. (1982) Metronidazole. Med Clin North Am\n                           66, 121\u2013133.","journal-title":"Med Clin North Am"},{"key":"2_CR129","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jcp.34.6.645","volume":"34","author":"A Krook","year":"1981","unstructured":"Krook A, Lindstrom B, Kjellander J, Jarnerot G and Bodin L. (1981) Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn\u2019s disease and healthy individuals. J Clin Pathol\n                           34, 645\u2013650.","journal-title":"J Clin Pathol"},{"key":"2_CR130","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","volume":"46","author":"T Pelaez","year":"2002","unstructured":"Pelaez T, Alcala L, Alonso R, Rodriguez-Creixems M, Garcia-Lechuz JM and Bouza E. (2002) Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother\n                           46, 1647\u20131650.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR131","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1128\/AAC.43.11.2607","volume":"43","author":"F Barbut","year":"1999","unstructured":"Barbut F, Decre D, Burghoffer B, et al. (1999) Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother\n                           43, 2607\u20132611.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR132","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/jac\/48.5.741","volume":"48","author":"JS Brazier","year":"2001","unstructured":"Brazier JS, Fawley W, Freeman J and Wilcox MH. (2001) Reduced susceptibility of Clostridium difficile to metronidazole. J Antimicrob Chemother\n                           48, 741\u2013742.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR133","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diagmicrobio.2005.09.008","volume":"54","author":"J Bishara","year":"2006","unstructured":"Bishara J, Bloch Y, Garty M, Behor J and Samra Z. (2006) Antimicrobial resistance of Clostridium difficile isolates in a tertiary medical center, Israel. Diagn Microbiol Infect Dis\n                           54, 141\u2013144.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2_CR134","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/313955","volume":"31","author":"S Johnson","year":"2000","unstructured":"Johnson S, Sanchez JL and Gerding DN. (2000) Metronidazole resistance in Clostridium difficile. Clin Infect Dis\n                           31, 625\u2013626.","journal-title":"Clin Infect Dis"},{"key":"2_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0732-8893(98)00139-4","volume":"34","author":"SS Wong","year":"1999","unstructured":"Wong SS, Woo PC, Luk WK and Yuen KY. (1999) Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest. Diagn Microbiol Infect Dis\n                           34, 1\u20136.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2_CR136","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/00004836-200405000-00005","volume":"38","author":"A Fernandez","year":"2004","unstructured":"Fernandez A, Anand G and Friedenberg F. (2004) Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol\n                           38, 414\u2013418.","journal-title":"J Clin Gastroenterol"},{"key":"2_CR137","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/430317","volume":"40","author":"DN Gerding","year":"2005","unstructured":"Gerding DN. (2005) Metronidazole for Clostridium difficile-associated disease: is it okay for mom? Clin Infect Dis\n                           40, 1598\u20131600.","journal-title":"Clin Infect Dis"},{"key":"2_CR138","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/01.mcg.0000190761.80615.0f","volume":"40","author":"S Modena","year":"2006","unstructured":"Modena S, Gollamudi S and Friedenberg F. (2006) Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea. J Clin Gastroenterol\n                           40, 49\u201354.","journal-title":"J Clin Gastroenterol"},{"key":"2_CR139","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10096-001-0658-0","volume":"21","author":"MJ Leroi","year":"2002","unstructured":"Leroi MJ, Siarakas S and Gottlieb T. (2002) E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid. Eur J Clin Microbiol Infect Dis\n                           21, 72\u201374.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2_CR140","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/BF01645961","volume":"12","author":"S Cronberg","year":"1984","unstructured":"Cronberg S, Castor B and Thoren A. (1984) Fusidic acid for the treatment of antibiotic-associated colitis induced by Clostridium difficile. Infection\n                           12, 276\u2013279.","journal-title":"Infection"},{"key":"2_CR141","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/jac\/dkh278","volume":"54","author":"M Wullt","year":"2004","unstructured":"Wullt M and Odenholt I. (2004) A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea. J Antimicrob Chemother\n                           54, 211\u2013216.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR142","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1128\/AAC.00019-06","volume":"50","author":"T Nor\u00e9n","year":"2006","unstructured":"Nor\u00e9n T, Wullt M, \u00c5kerlund T, B\u00e4ck E, Odenholt I and Burman LG. (2006) Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid. Antimicrob Agents Chemother\n                           50, 3028\u20133032.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR143","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1046\/j.1365-2958.2003.03307.x","volume":"47","author":"S Besier","year":"2003","unstructured":"Besier S, Ludwig A, Brade V and Wichelhaus TA. (2003) Molecular analysis of fusidic acid resistance in Staphylococcus aureus. Mol Microbiol\n                           47, 463\u2013469.","journal-title":"Mol Microbiol"},{"key":"2_CR144","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1128\/AAC.01283-06","volume":"51","author":"T Noren","year":"2007","unstructured":"Noren T, \u00c5kerlund T, Wullt M, Burman LG and Unemo M. (2007) Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile. Antimicrob Agents Chemother\n                           51, 1840\u20131843.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR145","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00004836-198704000-00009","volume":"9","author":"BP Buggy","year":"1987","unstructured":"Buggy BP, Fekety R and Silva J, Jr. (1987) Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol\n                           9, 155\u2013159.","journal-title":"J Clin Gastroenterol"},{"key":"2_CR146","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1086\/506354","volume":"43","author":"D Lagrotteria","year":"2006","unstructured":"Lagrotteria D, Holmes S, Smieja M, Smaill F and Lee C. (2006) Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. Clin Infect Dis\n                           43, 547\u2013552.","journal-title":"Clin Infect Dis"},{"key":"2_CR147","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1128\/AAC.33.7.1125","volume":"33","author":"F de Lalla","year":"1989","unstructured":"de Lalla F, Privitera G, Rinaldi E, Ortisi G, Santoro D and Rizzardini G. (1989) Treatment of Clostridium difficile-associated disease with teicoplanin. Antimicrob Agents Chemother\n                           33, 1125\u20131127.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2_CR148","doi-asserted-by":"publisher","first-page":"iii31","DOI":"10.1093\/jac\/dkg274","volume":"51","author":"MA Montecalvo","year":"2003","unstructured":"Montecalvo MA. (2003) Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother\n                           51(Suppl 3), iii31\u2013iii35.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR149","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1128\/AAC.34.3.413","volume":"34","author":"EA Somner","year":"1990","unstructured":"Somner EA and Reynolds PE. (1990) Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob Agents Chemother\n                           34, 413\u2013419.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR150","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1073\/pnas.102192099","volume":"99","author":"P Cudic","year":"2002","unstructured":"Cudic P, Kranz JK, Behenna DC, et al. (2002) Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation. Proc Natl Acad Sci USA\n                           99, 7384\u20137389.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR151","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/AAC.49.3.1157-1159.2005","volume":"49","author":"T Pelaez","year":"2005","unstructured":"Pelaez T, Alcala L, Alonso R, et al. (2005) In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole. Antimicrob Agents Chemother\n                           49, 1157\u20131159.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR152","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1128\/AAC.48.6.2280-2282.2004","volume":"48","author":"G Ackermann","year":"2004","unstructured":"Ackermann G, Loffler B, Adler D and Rodloff AC. (2004) In vitro activity of OPT-80 against Clostridium difficile. Antimicrob Agents Chemother\n                           48, 2280\u20132282.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR153","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1128\/AAC.44.9.2254-2258.2000","volume":"44","author":"CS McVay","year":"2000","unstructured":"McVay CS and Rolfe RD. (2000) In vitro and in vivo activities of nitazoxanide against Clostridium difficile. Antimicrob Agents Chemother\n                           44, 2254\u20132258.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR154","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1086\/506387","volume":"43","author":"JG Bartlett","year":"2006","unstructured":"Bartlett JG. (2006) New drugs for Clostridium difficile infection. Clin Infect Dis\n                           43, 428\u2013431.","journal-title":"Clin Infect Dis"},{"key":"2_CR155","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/00042737-199611000-00004","volume":"8","author":"CP Kelly","year":"1996","unstructured":"Kelly CP. (1996) Immune response to Clostridium difficile infection. Eur J Gastroenterol Hepatol\n                           8, 1048\u20131053.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2_CR156","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","volume":"357","author":"L Kyne","year":"2001","unstructured":"Kyne L, Warny M, Qamar A and Kelly CP. (2001) Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet\n                           357, 189\u2013193.","journal-title":"Lancet"},{"key":"2_CR157","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF01642866","volume":"13","author":"B Aronsson","year":"1985","unstructured":"Aronsson B, Granstrom M, Mollby R and Nord CE. (1985) Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection\n                           13, 97\u2013101.","journal-title":"Infection"},{"key":"2_CR158","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0732-8893(94)90021-3","volume":"18","author":"AE Bacon 3rd","year":"1994","unstructured":"Bacon AE, 3rd and Fekety R. (1994) Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea. Diagn Microbiol Infect Dis\n                           18, 205\u2013209.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2_CR159","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/gut.51.3.456","volume":"51","author":"IL Beales","year":"2002","unstructured":"Beales IL. (2002) Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea. Gut\n                           51, 456.","journal-title":"Gut"},{"key":"2_CR160","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/gut.41.3.366","volume":"41","author":"J Salcedo","year":"1997","unstructured":"Salcedo J, Keates S, Pothoulakis C, et al. (1997) Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut\n                           41, 366\u2013370.","journal-title":"Gut"},{"key":"2_CR161","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/17843286.1995.11718419","volume":"50","author":"M Warny","year":"1995","unstructured":"Warny M, Denie C, Delmee M and Lefebvre C. (1995) Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A. Acta Clin Belg\n                           50, 36\u201339.","journal-title":"Acta Clin Belg"},{"key":"2_CR162","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/AAC.40.2.373","volume":"40","author":"CP Kelly","year":"1996","unstructured":"Kelly CP, Pothoulakis C, Vavva F, et al. (1996) Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins. Antimicrob Agents Chemother\n                           40, 373\u2013379.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR163","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/iai.59.6.2215-2218.1991","volume":"59","author":"DM Lyerly","year":"1991","unstructured":"Lyerly DM, Bostwick EF, Binion SB and Wilkins TD. (1991) Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun\n                           59, 2215\u20132218.","journal-title":"Infect Immun"},{"key":"2_CR164","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/AAC.41.2.236","volume":"41","author":"CP Kelly","year":"1997","unstructured":"Kelly CP, Chetham S, Keates S, et al. (1997) Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrob Agents Chemother\n                           41, 236\u2013241.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR165","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/infdis\/150.1.57","volume":"150","author":"K Kim","year":"1984","unstructured":"Kim K, Pickering LK, DuPont HL, Sullivan N and Wilkins T. (1984) In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. J Infect Dis\n                           150, 57\u201362.","journal-title":"J Infect Dis"},{"key":"2_CR166","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1128\/IAI.71.3.1608-1610.2003","volume":"71","author":"S Aboudola","year":"2003","unstructured":"Aboudola S, Kotloff KL, Kyne L, et al. (2003) Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun\n                           71, 1608\u20131610.","journal-title":"Infect Immun"},{"key":"2_CR167","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","volume":"128","author":"S Sougioultzis","year":"2005","unstructured":"Sougioultzis S, Kyne L, Drudy D, et al. (2005) Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology\n                           128, 764\u2013770.","journal-title":"Gastroenterology"},{"key":"2_CR168","first-page":"67","volume":"143","author":"EW Kreutzer","year":"1978","unstructured":"Kreutzer EW and Milligan FD. (1978) Treatment of antibiotic-associated pseudomembranous colitis with cholestyramine resin. Johns Hopkins Med J\n                           143, 67\u201372.","journal-title":"Johns Hopkins Med J"},{"key":"2_CR169","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/iai.34.3.1036-1043.1981","volume":"34","author":"NS Taylor","year":"1981","unstructured":"Taylor NS, Thorne GM and Bartlett JG. (1981) Comparison of two toxins produced by Clostridium difficile. Infect Immun\n                           34, 1036\u20131043.","journal-title":"Infect Immun"},{"key":"2_CR170","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1086\/506349","volume":"43","author":"TJ Louie","year":"2006","unstructured":"Louie TJ, Peppe J, Watt CK, et al. (2006) Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis\n                           43, 411\u2013420.","journal-title":"Clin Infect Dis"},{"key":"2_CR171","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2002.11.1345","volume":"112","author":"AM Joyce","year":"2002","unstructured":"Joyce AM and Burns DL. (2002) Recurrent Clostridium difficile colitis. Tackling a tenacious nosocomial infection. Postgrad Med\n                           112, 53\u20134, 7\u20138, 65 passim.","journal-title":"Postgrad Med"},{"key":"2_CR172","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/gut.49.1.152","volume":"49","author":"L Kyne","year":"2001","unstructured":"Kyne L and Kelly CP. (2001) Recurrent Clostridium difficile diarrhoea. Gut\n                           49, 152\u2013153.","journal-title":"Gut"},{"key":"2_CR173","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1086\/501553","volume":"20","author":"LV McFarland","year":"1999","unstructured":"McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW and Greenberg RN. (1999) Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol\n                           20, 43\u201350.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2_CR174","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","volume":"97","author":"LV McFarland","year":"2002","unstructured":"McFarland LV, Elmer GW and Surawicz CM. (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol\n                           97, 1769\u20131775.","journal-title":"Am J Gastroenterol"},{"key":"2_CR175","first-page":"867","volume":"80","author":"FJ Tedesco","year":"1985","unstructured":"Tedesco FJ, Gordon D and Fortson WC. (1985) Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol\n                           80, 867\u2013868.","journal-title":"Am J Gastroenterol"},{"key":"2_CR176","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/0140-6736(90)90400-Y","volume":"335","author":"MI Issack","year":"1990","unstructured":"Issack MI and Elliott TS. (1990) Clostridium difficile carriage after infection. Lancet\n                           335, 610\u2013611.","journal-title":"Lancet"},{"key":"2_CR177","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0195-6701(98)90062-7","volume":"38","author":"MH Wilcox","year":"1998","unstructured":"Wilcox MH, Fawley WN, Settle CD and Davidson A. (1998) Recurrence of symptoms in Clostridium difficile infection \u2013 relapse or reinfection? J Hosp Infect\n                           38, 93\u2013100.","journal-title":"J Hosp Infect"},{"key":"2_CR178","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","volume":"38","author":"F Barbut","year":"2000","unstructured":"Barbut F, Richard A, Hamadi K, Chomette V, Burghoffer B and Petit JC. (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol\n                           38, 2386\u20132388.","journal-title":"J Clin Microbiol"},{"key":"2_CR179","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1469-0691.1997.tb00242.x","volume":"3","author":"JM Hamilton-Miller","year":"1997","unstructured":"Hamilton-Miller JM. (1997) Living in the \u2018post-antibiotic era\u2019: could the use of probiotics be an effective strategy? Clin Microbiol Infect\n                           3, 2\u20133.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR180","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","volume":"271","author":"LV McFarland","year":"1994","unstructured":"McFarland LV, Surawicz CM, Greenberg RN, et al. (1994) A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Assoc\n                           271, 1913\u20131918.","journal-title":"J Am Med Assoc"},{"key":"2_CR181","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1086\/318130","volume":"31","author":"CM Surawicz","year":"2000","unstructured":"Surawicz CM, McFarland LV, Greenberg RN, et al. (2000) The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis\n                           31, 1012\u20131017.","journal-title":"Clin Infect Dis"},{"key":"2_CR182","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0140-6736(87)92646-8","volume":"2","author":"SL Gorbach","year":"1987","unstructured":"Gorbach SL, Chang TW and Goldin B. (1987) Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet\n                           2, 1519.","journal-title":"Lancet"},{"key":"2_CR183","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0025-6196(11)62106-X","volume":"76","author":"MR Thomas","year":"2001","unstructured":"Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL and Lohse CM. (2001) Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial. Mayo Clin Proc\n                           76, 883\u2013889.","journal-title":"Mayo Clin Proc"},{"key":"2_CR184","first-page":"95","volume":"26","author":"K Orrhage","year":"2000","unstructured":"Orrhage K and Nord CE. (2000) Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res\n                           26, 95\u2013111.","journal-title":"Drugs Exp Clin Res"},{"key":"2_CR185","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","volume":"101","author":"LV McFarland","year":"2006","unstructured":"McFarland LV. (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol\n                           101, 812\u2013822.","journal-title":"Am J Gastroenterol"},{"key":"2_CR186","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/BF01536805","volume":"35","author":"MB Kimmey","year":"1990","unstructured":"Kimmey MB, Elmer GW, Surawicz CM and McFarland LV. (1990) Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Dig Dis Sci\n                           35, 897\u2013901.","journal-title":"Dig Dis Sci"},{"key":"2_CR187","first-page":"1285","volume":"84","author":"CM Surawicz","year":"1989","unstructured":"Surawicz CM, McFarland LV, Elmer G and Chinn J. (1989) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol\n                           84, 1285\u20131287.","journal-title":"Am J Gastroenterol"},{"key":"2_CR188","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1286-4579(02)01592-7","volume":"4","author":"D Czerucka","year":"2002","unstructured":"Czerucka D and Rampal P. (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect\n                           4, 733\u2013739.","journal-title":"Microbes Infect"},{"key":"2_CR189","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/00005176-199508000-00016","volume":"21","author":"JA Biller","year":"1995","unstructured":"Biller JA, Katz AJ, Flores AF, Buie TM and Gorbach SL. (1995) Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr\n                           21, 224\u2013226.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2_CR190","first-page":"178","volume":"47","author":"TA Bowden Jr","year":"1981","unstructured":"Bowden TA, Jr., Mansberger AR, Jr. and Lykins LE. (1981) Pseudomembranous enterocolitis: mechanism for restoring floral homeostasis. Am Surg\n                           47, 178\u2013183.","journal-title":"Am Surg"},{"key":"2_CR191","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(83)90753-5","volume":"2","author":"A Schwan","year":"1983","unstructured":"Schwan A, Sjolin S, Trottestam U and Aronsson B. (1983) Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet\n                           2, 845.","journal-title":"Lancet"},{"key":"2_CR192","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1086\/379836","volume":"188","author":"MM Merrigan","year":"2003","unstructured":"Merrigan MM, Sambol SP, Johnson S and Gerding DN. (2003) Prevention of fatal Clostridium difficile-associated disease during continuous administration of clindamycin in hamsters. J Infect Dis\n                           188, 1922\u20131927.","journal-title":"J Infect Dis"},{"key":"2_CR193","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02097191","volume":"6","author":"D Seal","year":"1987","unstructured":"Seal D, Borriello SP, Barclay F, Welch A, Piper M and Bonnycastle M. (1987) Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol\n                           6, 51\u201353.","journal-title":"Eur J Clin Microbiol"},{"key":"2_CR194","unstructured":"NCCLS. (2007) Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard. In: Hecht DW, Citron DM, Cox M, et al., eds., 7th ed., NCCLS, Pennsylvania, 1\u201347."},{"key":"2_CR195","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/107662904323047817","volume":"10","author":"V Baverud","year":"2004","unstructured":"Baverud V, Gunnarsson A, Karlsson M and Franklin A. (2004) Antimicrobial susceptibility of equine and environmental isolates of Clostridium difficile. Microb Drug Resist\n                           10, 57\u201363.","journal-title":"Microb Drug Resist"},{"key":"2_CR196","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1046\/j.1469-0691.2000.00034-4.x","volume":"6","author":"I Poilane","year":"2000","unstructured":"Poilane I, Cruaud P, Torlotin JC and Collignon A. (2000) Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile. Clin Microbiol Infect\n                           6, 155\u2013156.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR197","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00005","volume":"128","author":"MW Climo","year":"1998","unstructured":"Climo MW, Israel DS, Wong ES, Williams D, Coudron P and Markowitz SM. (1998) Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med\n                           128, 989\u2013995.","journal-title":"Ann Intern Med"},{"key":"2_CR198","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1086\/428835","volume":"40","author":"YJ Tang-Feldman","year":"2005","unstructured":"Tang-Feldman YJ, Henderson JP, Ackermann G, et al. (2005) Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998. Clin Infect Dis\n                           40, 1537\u20131540.","journal-title":"Clin Infect Dis"},{"key":"2_CR199","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJM199911253412203","volume":"341","author":"S Johnson","year":"1999","unstructured":"Johnson S, Samore MH, Farrow KA, et al. (1999) Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med\n                           341, 1645\u20131651.","journal-title":"N Engl J Med"},{"key":"2_CR200","first-page":"61","volume":"55","author":"H Pituch","year":"2003","unstructured":"Pituch H, Obuch-Woszczatynski P, Meisel-Mikolajczyk F and Luczak M. (2003) Detection of ermB gene responsible for high level resistance to clindamycin (MLS type resistance) among Clostridium difficile strains isolated from antibiotic associated diarrhea (AAD). Med Dosw Mikrobiol\n                           55, 61\u201366.","journal-title":"Med Dosw Mikrobiol"},{"key":"2_CR201","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","volume":"118","author":"JA Linder","year":"2005","unstructured":"Linder JA, Huang ES, Steinman MA, Gonzales R and Stafford RS. (2005) Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med\n                           118, 259\u2013268.","journal-title":"Am J Med"},{"key":"2_CR202","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1086\/522187","volume":"45","author":"LV McFarland","year":"2007","unstructured":"McFarland LV, Clarridge JE, Beneda HW and Raugi GJ. (2007) Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration Health Care System. Clin Infect Dis\n                           45, 1141\u20131151.","journal-title":"Clin Infect Dis"},{"key":"2_CR203","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1086\/430315","volume":"40","author":"J Pepin","year":"2005","unstructured":"Pepin J, Alary ME, Valiquette L, et al. (2005) Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis\n                           40, 1591\u20131597.","journal-title":"Clin Infect Dis"},{"key":"2_CR204","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1128\/AAC.50.5.1890-1892.2006","volume":"50","author":"O Aspevall","year":"2006","unstructured":"Aspevall O, Lundberg A, Burman LG, \u00c5kerlund T and Svenungsson B. (2006) Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish University Hospital. Antimicrob Agents Chemother\n                           50, 1890\u20131892.","journal-title":"Antimicrob Agents Chemother"},{"key":"2_CR205","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2007.03.009","volume":"59","author":"C Schmidt","year":"2007","unstructured":"Schmidt C, Loffler B and Ackermann G. (2007) Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile. Diagn Microbiol Infect Dis\n                           59, 1\u20135.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2_CR206","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","volume":"34","author":"R Leclercq","year":"2002","unstructured":"Leclercq R. (2002) Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis\n                           34, 482\u2013492.","journal-title":"Clin Infect Dis"},{"key":"2_CR207","unstructured":"Nor\u00e9n T, B\u00e4ck E, Alriksson I and Unemo M. (2006) New antimicrobials and resistance in C. difficile isolates and the potential risk of Clostridium difficile-associated diarrhea. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, abstract E-742."},{"issue":"2","key":"2_CR208","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1093\/clinids\/12.Supplement_2.S192","volume":"12","author":"S Tabaqchali","year":"1990","unstructured":"Tabaqchali S. (1990) Epidemiologic markers of Clostridium difficile. Rev Infect Dis\n                           12(Suppl 2), S192\u2013S199.","journal-title":"Rev Infect Dis"},{"key":"2_CR209","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1128\/jcm.33.12.3169-3173.1995","volume":"33","author":"YJ Tang","year":"1995","unstructured":"Tang YJ, Houston ST, Gumerlock PH, et al. (1995) Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates. J Clin Microbiol\n                           33, 3169\u20133173.","journal-title":"J Clin Microbiol"},{"key":"2_CR210","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1128\/jcm.16.6.1096-1101.1982","volume":"16","author":"J Wust","year":"1982","unstructured":"Wust J, Sullivan NM, Hardegger U and Wilkins TD. (1982) Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol\n                           16, 1096\u20131101.","journal-title":"J Clin Microbiol"},{"key":"2_CR211","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1348-0421.1981.tb00091.x","volume":"25","author":"S Nakamura","year":"1981","unstructured":"Nakamura S, Serikawa T, Mikawa M, Nakashio S, Yamakawa K and Nishida S. (1981) Agglutination, toxigenicity and sorbitol fermentation of Clostridium difficile. Microbiol Immunol\n                           25, 863\u2013870.","journal-title":"Microbiol Immunol"},{"key":"2_CR212","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jcm.21.3.323-327.1985","volume":"21","author":"M Delmee","year":"1985","unstructured":"Delmee M, Homel M and Wauters G. (1985) Serogrouping of Clostridium difficile strains by slide agglutination. J Clin Microbiol\n                           21, 323\u2013327.","journal-title":"J Clin Microbiol"},{"key":"2_CR213","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/jcm.26.1.41-46.1988","volume":"26","author":"ME Mulligan","year":"1988","unstructured":"Mulligan ME, Peterson LR, Kwok RY, Clabots CR and Gerding DN. (1988) Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol\n                           26, 41\u201346.","journal-title":"J Clin Microbiol"},{"key":"2_CR214","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/jcp.40.7.771","volume":"40","author":"PG Peerbooms","year":"1987","unstructured":"Peerbooms PG, Kuijt P and Maclaren DM. (1987) Application of chromosomal restriction endonuclease digest analysis for use as typing method for Clostridium difficile. J Clin Pathol\n                           40, 771\u2013776.","journal-title":"J Clin Pathol"},{"key":"2_CR215","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/jcm.25.12.2402-2404.1987","volume":"25","author":"BW Wren","year":"1987","unstructured":"Wren BW and Tabaqchali S. (1987) Restriction endonuclease DNA analysis of Clostridium difficile. J Clin Microbiol\n                           25, 2402\u20132404.","journal-title":"J Clin Microbiol"},{"key":"2_CR216","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1093\/nar\/18.24.7213","volume":"18","author":"J Welsh","year":"1990","unstructured":"Welsh J and McClelland M. (1990) Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res\n                           18, 7213\u20137218.","journal-title":"Nucleic Acids Res"},{"key":"2_CR217","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1046\/j.1198-743x.2001.00288.x","volume":"7","author":"JS Brazier","year":"2001","unstructured":"Brazier JS. (2001) Typing of Clostridium difficile. Clin Microbiol Infect\n                           7, 428\u2013431.","journal-title":"Clin Microbiol Infect"},{"key":"2_CR218","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1128\/jcm.32.6.1591-1593.1994","volume":"32","author":"GE Killgore","year":"1994","unstructured":"Killgore GE and Kato H. (1994) Use of arbitrary primer PCR to type Clostridium difficile and comparison of results with those by immunoblot typing. J Clin Microbiol\n                           32, 1591\u20131593.","journal-title":"J Clin Microbiol"},{"key":"2_CR219","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/jcm.33.8.2016-2021.1995","volume":"33","author":"G Martirosian","year":"1995","unstructured":"Martirosian G, Kuipers S, Verbrugh H, van Belkum A and Meisel-Mikolajczyk F. (1995) PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital. J Clin Microbiol\n                           33, 2016\u20132021.","journal-title":"J Clin Microbiol"},{"key":"2_CR220","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0195-6701(94)90105-8","volume":"28","author":"M Wilks","year":"1994","unstructured":"Wilks M and Tabaqchali S. (1994) Typing of Clostridium difficile by polymerase chain reaction with an arbitrary primer. J Hosp Infect\n                           28, 231\u2013234.","journal-title":"J Hosp Infect"},{"key":"2_CR221","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1574-6968.1993.tb06567.x","volume":"114","author":"F Barbut","year":"1993","unstructured":"Barbut F, Mario N, Delmee M, Gozian J and Petit JC. (1993) Genomic fingerprinting of Clostridium difficile isolates by using a random amplified polymorphic DNA (RAPD) assay. FEMS Microbiol Lett\n                           114, 161\u2013166.","journal-title":"FEMS Microbiol Lett"},{"key":"2_CR222","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0195-6701(97)90099-2","volume":"35","author":"F Lemann","year":"1997","unstructured":"Lemann F, Chambon C, Barbut F, et al. (1997) Arbitrary primed PCR rules out Clostridium difficile cross-infection among patients in a haematology unit. J Hosp Infect\n                           35, 107\u2013115.","journal-title":"J Hosp Infect"},{"key":"2_CR223","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/jcm.34.5.1153-1157.1996","volume":"34","author":"MC Collier","year":"1996","unstructured":"Collier MC, Stock F, DeGirolami PC, Samore MH and Cartwright CP. (1996) Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile. J Clin Microbiol\n                           34, 1153\u20131157.","journal-title":"J Clin Microbiol"},{"key":"2_CR224","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1099\/00221287-139-12-3089","volume":"139","author":"V Gurtler","year":"1993","unstructured":"Gurtler V. (1993) Typing of Clostridium difficile strains by PCR-amplification of variable length 16S-23S rDNA spacer regions. J Gen Microbiol\n                           139, 3089\u20133097.","journal-title":"J Gen Microbiol"},{"key":"2_CR225","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1128\/jcm.33.1.184-187.1995","volume":"33","author":"CP Cartwright","year":"1995","unstructured":"Cartwright CP, Stock F, Beekmann SE, Williams EC and Gill VJ. (1995) PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile. J Clin Microbiol\n                           33, 184\u2013187.","journal-title":"J Clin Microbiol"},{"key":"2_CR226","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1099\/00222615-47-2-117","volume":"47","author":"NM Al Saif","year":"1998","unstructured":"Al Saif NM, O\u2019Neill GL, Magee JT, Brazier JS and Duerden BI. (1998) PCR-ribotyping and pyrolysis mass spectrometry fingerprinting of environmental and hospital isolates of Clostridium difficile. J Med Microbiol\n                           47, 117\u2013121.","journal-title":"J Med Microbiol"},{"key":"2_CR227","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/BF01691381","volume":"14","author":"D Talon","year":"1995","unstructured":"Talon D, Bailly P, Delmee M, et al. (1995) Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients. Eur J Clin Microbiol Infect Dis\n                           14, 987\u2013993.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2_CR228","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/JCM.38.7.2484-2487.2000","volume":"38","author":"P Bidet","year":"2000","unstructured":"Bidet P, Lalande V, Salauze B, et al. (2000) Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol\n                           38, 2484\u20132487.","journal-title":"J Clin Microbiol"},{"key":"2_CR229","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1099\/0022-1317-50-8-720","volume":"50","author":"H Kato","year":"2001","unstructured":"Kato H, Kita H, Karasawa T, et al. (2001) Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol\n                           50, 720\u2013727.","journal-title":"J Med Microbiol"},{"key":"2_CR230","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1128\/JCM.40.1.101-104.2002","volume":"40","author":"CH Klaassen","year":"2002","unstructured":"Klaassen CH, van Haren HA and Horrevorts AM. (2002) Molecular fingerprinting of Clostridium difficile isolates: pulsed-field gel electrophoresis versus amplified fragment length polymorphism. J Clin Microbiol\n                           40, 101\u2013104.","journal-title":"J Clin Microbiol"},{"key":"2_CR231","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1128\/jcm.32.8.1963-1969.1994","volume":"32","author":"M Kristjansson","year":"1994","unstructured":"Kristjansson M, Samore MH, Gerding DN, et al. (1994) Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol\n                           32, 1963\u20131969.","journal-title":"J Clin Microbiol"},{"key":"2_CR232","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1099\/0022-1317-50-5-407","volume":"50","author":"P Spigaglia","year":"2001","unstructured":"Spigaglia P, Cardines R, Rossi S, Menozzi MG and Mastrantonio P. (2001) Molecular typing and long-term comparison of Clostridium difficile strains by pulsed-field gel electrophoresis and PCR-ribotyping. J Med Microbiol\n                           50, 407\u2013414.","journal-title":"J Med Microbiol"},{"key":"2_CR233","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/jcm.34.12.3049-3055.1996","volume":"34","author":"P van Dijck","year":"1996","unstructured":"van Dijck P, Avesani V and Delmee M. (1996) Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C. J Clin Microbiol\n                           34, 3049\u20133055.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2_CR234","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1086\/516190","volume":"25","author":"JS Brazier","year":"1997","unstructured":"Brazier JS, Mulligan ME, Delmee M and Tabaqchali S. (1997) Preliminary findings of the international typing study on Clostridium difficile. International Clostridium difficile Study Group. Clin Infect Dis\n                           25 (Suppl 2), S199\u2013S201.","journal-title":"Clin Infect Dis"},{"key":"2_CR235","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1128\/JCM.40.6.2079-2083.2002","volume":"40","author":"F Barbut","year":"2002","unstructured":"Barbut F, Lalande V, Burghoffer B, Thien HV, Grimprel E and Petit JC. (2002) Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol\n                           40, 2079\u20132083.","journal-title":"J Clin Microbiol"},{"key":"2_CR236","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1099\/00221287-147-2-439","volume":"147","author":"M Rupnik","year":"2001","unstructured":"Rupnik M, Brazier JS, Duerden BI, Grabnar M and Stubbs SL. (2001) Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology\n                           147, 439\u2013447.","journal-title":"Microbiology"},{"key":"2_CR237","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/JCM.37.2.461-463.1999","volume":"37","author":"SL Stubbs","year":"1999","unstructured":"Stubbs SL, Brazier JS, O\u2019Neill GL and Duerden BI. (1999) PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol\n                           37, 461\u2013463.","journal-title":"J Clin Microbiol"},{"key":"2_CR238","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/JCM.36.8.2240-2247.1998","volume":"36","author":"M Rupnik","year":"1998","unstructured":"Rupnik M, Avesani V, Janc M, von Eichel-Streiber C and Delmee M. (1998) A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol\n                           36, 2240\u20132247.","journal-title":"J Clin Microbiol"},{"key":"2_CR239","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1128\/JCM.01484-07","volume":"46","author":"G Killgore","year":"2008","unstructured":"Killgore G, Thompson A, Johnson S, et al. (2008) Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol\n                           46, 431\u2013437.","journal-title":"J Clin Microbiol"}],"container-title":["Methods in Molecular Biology","Clostridium difficile"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-60327-365-7_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T10:14:08Z","timestamp":1710843248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-60327-365-7_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9781603273640","9781603273657"],"references-count":239,"URL":"https:\/\/doi.org\/10.1007\/978-1-60327-365-7_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]},"assertion":[{"value":"8 March 2010","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}